RA10.04: POSTOPERATIVE PNEUMONIA IS ASSOCIATED WITH SHORT-TERM AND LONG-TERM MORTALITY OF DEFINITIVE CHEMORADIOTHERAPY FOLLOWED BY SALVAGE ESOPHAGECTOMY FOR ESOPHAGEAL CANCER

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 43-43
Author(s):  
Masashi Takeuchi ◽  
Hirofumi Kawakubo ◽  
Shuhei Mayanagi ◽  
Kazumasa Fukuda ◽  
Rieko Nakamura ◽  
...  

Abstract Background Although definitive chemoradiotherapy (CRT) with salvage esophagectomy has improved overall survival (OS) for esophageal cancer, it is a more invasive approach than neoadjuvant CRT followed by surgery or surgery alone, and causes high mortality after surgery. The purpose of this study was to investigate the short and long-term outcomes of salvage esophagectomy, to determine their prognostic factors, and to create a prediction model for OS using a classification and regression tree (CART). Methods Ninety patients who had undergone CRT followed by esophagectomy for thoracic esophageal cancer at Keio University Hospital, Tokyo, Japan, between June 1994 and August 2014 were identified for this study. We divided the 90 patients into two groups—the salvage group and the neoadjuvant group—according to the dose of irradiation of CRT. Forty-four patients who underwent CRT with radiation dose less than 50 Gy, followed by planned esophagectomy, were allocated to the neoadjuvant group. Forty-six patients with salvage esophagectomy for locally recurrent or residual cancer after definitive CRT (greater than 50 Gy) were allocated to the salvage group. Results Patients from the salvage group tended to have a lower OS (median survival: Salvage, 25 months vs neoadjuvant, 50 months, P = 0.149). In the salvage group, pneumonia and age were identified as factors predictive of in-hospital mortality. OS was significantly lower in patients with postoperative pneumonia and female gender. We set the prediction model for OS in the salvage group using survival CART. The group of R1/2 resection aged ≥ 56.5 years and the group suffering from postoperative pneumonia were the groups at highest risk; the area under the curve was 0.72. Conclusion The present study demonstrates the short-term and long-term prognostic factors of salvage esophagectomy after definitive CRT for esophageal cancer. Achieving improvement in OS after salvage surgery requires increased R0 resection rates and decreased pulmonary complications. Both informed decision making in the adoption of salvage surgery and specific plans to reduce pneumonia through means such as pulmonary rehabilitation are required. Disclosure All authors have declared no conflicts of interest.

2018 ◽  
Vol 22 (11) ◽  
pp. 1881-1889 ◽  
Author(s):  
Masashi Takeuchi ◽  
Hirofumi Kawakubo ◽  
Shuhei Mayanagi ◽  
Kayo Yoshida ◽  
Kazumasa Fukuda ◽  
...  

2014 ◽  
Vol 99 (5) ◽  
pp. 640-644
Author(s):  
Yoshihiko Fujinaka ◽  
Masaru Morita ◽  
Takefumi Ohga ◽  
Yoshihiro Kakeji ◽  
Tokujiro Yano ◽  
...  

Abstract The prognosis of esophageal cancer with distant metastasis is dismal. We report a 70-year-old man with esophageal cancer and multiple lung and lymph node metastases. Complete response was achieved following definitive chemoradiotherapy. Twenty-four months after the initial chemoradiotherapy, local recurrence was detected but there was no evidence of distant metastasis. Therefore, the patient underwent salvage esophagectomy. The surgery was well tolerated without any postoperative complications. The patient is still alive 48 months after the salvage surgery. Our experience suggests that salvage esophagectomy is an important component of multimodal therapy for the recurrence of esophageal cancer.


2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 160-160
Author(s):  
Annelijn Slaman ◽  
Wietse Eshuis ◽  
Werner Draaisma ◽  
Suzanne Gisbertz ◽  
Jacques Bergman ◽  
...  

Abstract Background Definitive chemoradiotherapy for esophageal cancer can be a treatment option in selected patients. In patients with locoregional recurrence after definitive chemoradiotherapy, additional curative esophagectomy may be possible, but evidence for this ‘salvage’ esophagectomy is limited. The aim of this study was to evaluate clinical outcomes of salvage esophagectomy after definitive chemoradiotherapy. Methods A prospectively maintained database was used to select patients who underwent esophagectomy for locoregional recurrent cancer of the esophagus or gastroesophageal junction after dCRTx (‘salvage esophagectomy’) and patients who underwent curative esophagectomy following neoadjuvant chemoradiotherapy (‘nCRTx esophagectomy’) between January 2013 and January 2018. Patients underwent salvage resection without direct reconstruction (2-stage salvage procedure) or with a direct reconstruction. Perioperative outcomes of salvage esophagectomy were compared to nCRTX esophagectomy. Oncologic outcomes were evaluated using the Kaplan-Meier method. Results A total of 16 patients underwent salvage esophagectomy and 330 patients underwent nCRTx esophagectomy during the study period. Direct reconstruction was performed in 3 patients (13.3%) of the salvage group versus 328 patients (99.1%) who underwent nCRTx esophagectomy (P < 0.001). R0-resection rate was higher after esophagectomy following nCRTx than after salvage surgery (97.0% versus 68.8% respectively, P < 0.001). Difference in morbidity did not reach statistical significance (58.8% versus 81.3% respectively, P = 0.115). The combined (30-day and in-hospital) mortality and 90-day mortality were significantly higher after salvage esophagectomy (2.4% versus 31.1% and 4.7% versus 42.9%, both P < 0.001). Median follow-up of all surviving patients was 21.4 months (IQR, 10.0–36.2). The overall survival in the salvage group had a median of 4.3 months (95% CI, 0–10.0) versus a median of 43.7 months (95% CI, 33.9–53.5) in the nCRTx esophagectomy group. The cumulative 1-year and 3-year survival of the salvage group were 42.2% and 28.1%. Within 5 years after surgery all patients in the salvage esophagectomy group had died. Conclusion Definitive chemoradiotherapy followed by esophagectomy for esophageal carcinomas is associated with a high proportion of R1 resections and high mortality rates. It is recommended to evaluate these results in larger patient cohorts. Salvage resections should only be performed in strongly selected patients. Disclosure All authors have declared no conflicts of interest.


2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 109-109
Author(s):  
Toshiaki Shichinohe ◽  
Soichi Murakami ◽  
Yuma Ebihara ◽  
Yo Kurashima ◽  
Satoshi Hirano

Abstract Background Salvage surgery is only one therapeutic option which enable to cure intractable esophageal cancer after definitive chemo-radiotherapy. Although video-assisted esophagectomy (VAE) is now widely accepted as a standard operation for primary esophageal cancer, the application of VAE to salvage surgery is still controversial since salvage surgery is known as high-risk operation. In this study, we investigated 27 cases of salvage surgery and assessed the feasibility of the operation by analyzing their short and long-term outcomes. Methods VAE was applied to 26 cases and laparoscopic lymphadenectomy was applied to 1 case. The procedure of the VAE included prone position esophagectomy (n = 8), esophagectomy by hand-assisted thoracoscopic surgery (n = 10) and mediastinoscope-assisted transhiatal esophagectomy (n = 5). Our current operative procedure after year 2010 is PPE. The fields of lymph node dissection for salvage esophagectomy have been limited to the stations that had metastasis before CRT and the lymphatic stations which newly recognized as suspected metastasis. Postoperative complications were defined according to the Clavien-Dindo classification. Results Video assisted surgery was applied to 96% of patients including one case of laparoscopic abdominal lymphadenectomy. One case required open surgery for suspicious of direct invasion of tumor. R0 rate of the operations was scored 78%. Postoperative complication rate defined as ≥ C-D II plus any grade of anastomotic leakage and recurrent laryngeal nerve palsy was 63%. The rate of anastomotic leakage, respiratory complication, and RLN palsy were 23%, 15%, and 12%, respectively. Operative death was 0%, whereas in-hospital mortality was 3.7%. Overall survival of esophagectomy cases showed 24% in 3-year and 8% in 5-year. According to subgroup analysis by pathological R status after operation, the survival outcomes of pR0 group (n = 20) reached 32% in 3-year and 10% in 5-year OS, whereas no patient reached 3-year survival in pR1/2 group (n = 6; P = 0.02). Conclusion Although salvage VAE should be applied in high-experienced institutions under the careful consideration of indication, it appears to be balanced operation for safety, and less invasiveness, as well as curability. Disclosure All authors have declared no conflicts of interest.


2018 ◽  
Vol 69 (6) ◽  
pp. 327-334
Author(s):  
Takashi Matsumoto ◽  
Naoya Yoshida ◽  
Yoshifumi Baba ◽  
Yohei Nagai ◽  
Hideo Baba

2021 ◽  
Vol 80 ◽  
pp. 105617
Author(s):  
Wataru Hirose ◽  
Yusuke Taniyama ◽  
Fumiyoshi Fujishima ◽  
Chiaki Sato ◽  
Michiaki Unno ◽  
...  

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Tarun Jindal ◽  
Ankush Sarwal ◽  
Pravin Pawar ◽  
M. Dhanalakshmi ◽  
Neeraj Subedi

Abstract Background The presence of isolated metachronous adrenal metastasis in patients with esophageal cancer is rare. There is significant controversy regarding the management of such patients. Adrenal metastasectomy has been shown to be of benefit in some reports. Minimally invasive approach, although the gold standard for adrenalectomy, has not been used commonly in a postesophagectomy setting owing to the anticipated technical difficulties. We describe one such case wherein this approach helped in early recovery and long-term survival. Case presentation A 59-year-old male of Asian ethnicity presented with an isolated left adrenal nodule, 3 years after an Ivor Lewis esophagectomy for a lower esophageal adenocarcinoma. The biopsy of the nodule was suggestive of metastatic adenocarcinoma. The patient underwent laparoscopic excision of the left adrenal gland. Conclusion Adrenal metastasectomy, in postesophagectomy patients can provide good oncological control. Laparoscopic approach, though technically challenging, can provide results equivalent to those of open surgery, albeit with less morbidity.


2021 ◽  
Vol 41 (7) ◽  
pp. 3523-3534
Author(s):  
PIOTR KULIG ◽  
PRZEMYSŁAW NOWAKOWSKI ◽  
MAREK SIERZĘGA ◽  
RADOSŁAW PACH ◽  
OLIWIA MAJEWSKA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document